LYRA

Lyra Therapeutics Inc.

Price

$0.20

return (12m)

-96.85%

p/e

-0.01

p/bv

-0.04

DIVIDEND YIELD

0.00%

LYRA price

Lyra Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LYRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1,900.00%

3 months

-63.17%

1 year

-96.85%

2 years

-98.58%

5 years

-99.95%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals LYRA

Valuation

P/E

-0.01

Sector -3.50

Industry -3.50

P/BV

-0.04

Sector 2.01

Industry 2.01

P/Revenue (PSR)

1.03

Sector 2.01

Industry 2.01

EV/EBITDA

2.27

Sector -223.67

Industry -223.67

EV/EBIT

2.24

Sector -47.92

Industry -47.92

P/EBITDA

-0.01

Sector -21.50

Industry -21.50

P/EBIT

-0.01

Sector -28.21

Industry -28.21

P/Total Assets

0.01

Sector 1.19

Industry 1.19

P/Net Current Assets

-0.01

Sector -10.26

Industry -10.26

P/Working Capital

0.06

Sector -167.98

Industry -167.98

EPS

-14.46

Sector -1.79

Industry -1.79

BVPS

-5.36

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

100.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-68,100.00%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-69,100.00%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

269.78%

Sector -56.67%

Industry -56.67%

ROA

-80.09%

Sector -59.91%

Industry -59.91%

ROIC

-97.20%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.71

Sector 2.89

Industry 2.89

Net Debt / EBITDA

2.33

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

2.30

Sector -8.06

Industry -8.06

Net Debt / Equity

1.48

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

-0.30

Sector 0.46

Industry 0.46

Liabilities/Assets

1.30

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

6.85%

Sector -

Industry -

5Y Earnings CAGR

-7.84%

Sector -

Industry -

Fundamentals LYRA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LYRA Lyra Therapeutics Inc.	$0.20	-96.85%	0.00%	-0.01	-0.04	269.78%	-100.00%
JNJ Johnson & Johnson	$269.99	56.71%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.66	23.21%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.96	22.44%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.24	-26.07%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.87	87.26%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.08	10.74%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.06	48.20%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$71.40	-50.11%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$385.65	38.85%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.85	33.10%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$112.45	44.52%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.65	25.89%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$508.34	32.68%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$225.38	52.58%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$990.32	34.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.02	29.13%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LYRA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Lyra Therapeutics

Lyra Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

21 years

Founded: 2005

2020

Time since IPO - 6 years

38

Employees

Lyra Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $400.00 Thousand, with shareholders equity totaling $-10.72 million.

The company employs approximately 38 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Lyra Therapeutics Inc. reported $390.00 Thousand in revenue, generating net income of $-28.92 million.

Key financial metrics include a P/E ratio of -0.01, a price-to-book (P/B) ratio of -0.04, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LYRA.

Market cap

$400.00 Thousand

Net worth

$-10.72 million

$-10,720,000.00

Assets

$36.11 million

$36,110,000.00

Total Shares Outstanding

2.00 million

2,000,000

Average Daily Trading Volume

$2.42 Thousand

$2,420.26

Sector

Health Care

Industry

Biotechnology

LYRA

LYRA revenue and profits

Financial Results LYRA

DRAG THE FRAME TO SEE MORE DATA

LYRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.65 25,89% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$225.38 52,58% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.99 56,71% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.96 22,44% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.87 87,26% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.08 9,00% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.66 23,21% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.65 25,89% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$225.38 52,58% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.99 56,71% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.96 22,44% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.87 87,26% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.08 9,00% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.66 23,21% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Lyra Therapeutics (LYRA) today?

A cotação de Lyra Therapeutics (LYRA) hoje está em US$ 0.20, com uma variação de -96.85% em relação ao último ano. A cotação de Lyra Therapeutics (LYRA) iniciou o ano negociando na casa dos US$ 3.08 e hoje está em US$ 0.20. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Lyra Therapeutics (LYRA) e dados de ações do Ibovespa e mercados internacionais.

Quando Lyra Therapeutics (LYRA) paga dividendos?

Lyra Therapeutics (LYRA) não distribuiu dividendos no último ano.

Is Lyra Therapeutics (LYRA) a good investment?

Atualmente, Lyra Therapeutics (LYRA) está cotada a US$ 0.20, com um P/L de -0.01, representando um desvio de -179% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -96.85 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -96.85%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Lyra Therapeutics (LYRA) stock?

Investir em ações de Lyra Therapeutics (LYRA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Lyra Therapeutics (LYRA) yield today?

A rentabilidade de Lyra Therapeutics (LYRA) foi de 1,900.00% no último mês, -96.85% no último ano e -99.95% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Lyra Therapeutics (LYRA) hoje, o investimento total seria de US$ 20.00, com base na cotação atual de US$ 0.20.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.63
Em 5 anos: US$ 0.010000
Em 10 anos: US$ 20.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LYRA

Lyra Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LYRA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING LYRA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Lyra Therapeutics

Lyra Therapeutics Inc.

United States

21 years

2020

38

PROFIT X PRICE LYRA

Financial Results LYRA

LYRA cash flow

Asset, Revenue and Profit Growth - LYRA

LYRA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions